LJL Biosystems
Sunnyvale
About LJL Biosystems
LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process. LJL's proprietary integrated technology platform is comprised of instrumentation and fluorescence-based and other assay technologies designed to provide a flexible solution to the current and evolving HTS requirements of drug discovery laboratories. The drug discovery process involves several stages including target identification, compound synthesis, assay development, screening and lead optimization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 1999)
- Ticker: nasdaq:LJLB
- Website: ljlbio.com
Industries & Categories
Biotechnology, Information Technology, Product Design
Canonical: https://fsome.com/organization/ljl-biosystems-2143404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.